From COVID Vaccines to HIV Prevention: Pharmaceutical Financing and Distribution for the Public’s Health

The complexity and inefficiency of the U.S. health care system complicates the distribution of life-saving medical technologies. When the public health is at stake, however, there are alternatives. The proposal for a national PrEP program published in this issue of the Journal applies some of the le...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharfstein, Joshua M., Conti, Rena M., Gee, Rebekah E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341206/
https://www.ncbi.nlm.nih.gov/pubmed/35902083
http://dx.doi.org/10.1017/jme.2022.32
Descripción
Sumario:The complexity and inefficiency of the U.S. health care system complicates the distribution of life-saving medical technologies. When the public health is at stake, however, there are alternatives. The proposal for a national PrEP program published in this issue of the Journal applies some of the lessons of the national COVID vaccine campaign to HIV prevention. In doing so, it draws on other examples of public health approaches to the financing of medical technology, from vaccines for children to hepatitis C treatment.

Ejemplares similares